Your browser doesn't support javascript.
loading
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation.
Malcikova, J; Tausch, E; Rossi, D; Sutton, L A; Soussi, T; Zenz, T; Kater, A P; Niemann, C U; Gonzalez, D; Davi, F; Gonzalez Diaz, M; Moreno, C; Gaidano, G; Stamatopoulos, K; Rosenquist, R; Stilgenbauer, S; Ghia, P; Pospisilova, S.
  • Malcikova J; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic.
  • Tausch E; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Rossi D; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Sutton LA; Hematology, Oncology Institute of Southern Switzerland, Institute of Oncology Research, Bellinzona, Switzerland.
  • Soussi T; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Zenz T; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Kater AP; Université Pierre et Marie Curie, Paris, France.
  • Niemann CU; INSERM, U1138, Centre de Recherche des Cordeliers, Paris, France.
  • Gonzalez D; Department of Oncology-Pathology, Karolinska Institutet, Cancer Center Karolinska, Stockholm, Sweden.
  • Davi F; Division of Hematology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
  • Gonzalez Diaz M; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands.
  • Moreno C; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • Gaidano G; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
  • Stamatopoulos K; Department of Hematology, Hôpital Pitié-Salpêtière, AP-HP, Sorbonne Universités-UPMC University, Paris, France.
  • Rosenquist R; Centro de Investigación del Cancer and Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), University of Salamanca, Salamanca, Spain.
  • Stilgenbauer S; Department of Haematology, Hospital de la Santa Creu I Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.
  • Ghia P; Division of Haematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Pospisilova S; Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
Leukemia ; 32(5): 1070-1080, 2018 05.
Article en En | MEDLINE | ID: mdl-29467486
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Análisis Mutacional de ADN / Leucemia Linfocítica Crónica de Células B / Genes p53 Tipo de estudio: Guideline / Prognostic_studies Límite: Humans País como asunto: Europa Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Análisis Mutacional de ADN / Leucemia Linfocítica Crónica de Células B / Genes p53 Tipo de estudio: Guideline / Prognostic_studies Límite: Humans País como asunto: Europa Idioma: En Año: 2018 Tipo del documento: Article